P2Y12 platelet receptor antagonist

This page covers all P2Y12 platelet receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting P2Y12 receptor.

Targets

P2Y12 receptor

Marketed (4)

• Ticagrelor- Delayed Administration · Massachusetts General Hospital · Cardiovascular
  Ticagrelor is a P2Y12 platelet receptor antagonist that inhibits platelet aggregation to prevent thrombotic events.
• Ticagrelor maintenance dose · Icahn School of Medicine at Mount Sinai · Cardiovascular
  Ticagrelor is a P2Y12 platelet receptor antagonist that irreversibly blocks ADP-induced platelet aggregation to prevent thrombotic events.
• Integral ticagrelor · Collegium Medicum w Bydgoszczy · Cardiovascular
  Ticagrelor is a P2Y12 platelet receptor antagonist that inhibits platelet aggregation and reduces thrombotic events.
• Ticagrelor loading dose · Icahn School of Medicine at Mount Sinai · Cardiovascular
  Ticagrelor is a P2Y12 platelet receptor antagonist that irreversibly blocks ADP-induced platelet aggregation to prevent thrombotic events.